These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 19028871)

  • 1. Antigen microarrays identify unique serum autoantibody signatures in clinical and pathologic subtypes of multiple sclerosis.
    Quintana FJ; Farez MF; Viglietta V; Iglesias AH; Merbl Y; Izquierdo G; Lucas M; Basso AS; Khoury SJ; Lucchinetti CF; Cohen IR; Weiner HL
    Proc Natl Acad Sci U S A; 2008 Dec; 105(48):18889-94. PubMed ID: 19028871
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antigen microarrays identify CNS-produced autoantibodies in RRMS.
    Quintana FJ; Farez MF; Izquierdo G; Lucas M; Cohen IR; Weiner HL
    Neurology; 2012 Feb; 78(8):532-9. PubMed ID: 22262743
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transglutaminase-6 is an autoantigen in progressive multiple sclerosis and is upregulated in reactive astrocytes.
    Cristofanilli M; Gratch D; Pagano B; McDermott K; Huang J; Jian J; Bates D; Sadiq SA
    Mult Scler; 2017 Nov; 23(13):1707-1715. PubMed ID: 28273770
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-Density Peptide Microarray Analysis of IgG Autoantibody Reactivities in Serum and Cerebrospinal Fluid of Multiple Sclerosis Patients.
    Hecker M; Fitzner B; Wendt M; Lorenz P; Flechtner K; Steinbeck F; Schröder I; Thiesen HJ; Zettl UK
    Mol Cell Proteomics; 2016 Apr; 15(4):1360-80. PubMed ID: 26831522
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epitope spreading as an early pathogenic event in pediatric multiple sclerosis.
    Quintana FJ; Patel B; Yeste A; Nyirenda M; Kenison J; Rahbari R; Fetco D; Hussain M; O'Mahony J; Magalhaes S; McGowan M; Johnson T; Rajasekharan S; Narayanan S; Arnold DL; Weiner HL; Banwell B; Bar-Or A;
    Neurology; 2014 Dec; 83(24):2219-26. PubMed ID: 25381299
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum autoantibodies to cell surface determinants in multiple sclerosis: a flow cytometric study.
    Lily O; Palace J; Vincent A
    Brain; 2004 Feb; 127(Pt 2):269-79. PubMed ID: 14662514
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lipids and lipid-reactive antibodies as biomarkers for multiple sclerosis.
    Quintana FJ; Yeste A; Weiner HL; Covacu R
    J Neuroimmunol; 2012 Jul; 248(1-2):53-7. PubMed ID: 22579051
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CSF oligoclonal band patterns reveal disease heterogeneity in multiple sclerosis.
    Villar LM; Masterman T; Casanova B; Gómez-Rial J; Espiño M; Sádaba MC; González-Porqué P; Coret F; Alvarez-Cermeño JC
    J Neuroimmunol; 2009 Jun; 211(1-2):101-4. PubMed ID: 19443047
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Galectin-8 as an immunosuppressor in experimental autoimmune encephalomyelitis and a target of human early prognostic antibodies in multiple sclerosis.
    Pardo E; Cárcamo C; Uribe-San Martín R; Ciampi E; Segovia-Miranda F; Curkovic-Peña C; Montecino F; Holmes C; Tichauer JE; Acuña E; Osorio-Barrios F; Castro M; Cortes P; Oyanadel C; Valenzuela DM; Pacheco R; Naves R; Soza A; González A
    PLoS One; 2017; 12(6):e0177472. PubMed ID: 28650992
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sperm-associated antigen 16 is a novel target of the humoral autoimmune response in multiple sclerosis.
    de Bock L; Somers K; Fraussen J; Hendriks JJ; van Horssen J; Rouwette M; Hellings N; Villar LM; Alvarez-Cermeño JC; Espiño M; Hupperts R; Jongen P; Damoiseaux J; Verbeek MM; De Deyn PP; D'hooghe M; Van Wijmeersch B; Stinissen P; Somers V
    J Immunol; 2014 Sep; 193(5):2147-56. PubMed ID: 25086173
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Involvement of cytotoxic Eomes-expressing CD4
    Raveney BJE; Sato W; Takewaki D; Zhang C; Kanazawa T; Lin Y; Okamoto T; Araki M; Kimura Y; Sato N; Sano T; Saito Y; Oki S; Yamamura T
    Proc Natl Acad Sci U S A; 2021 Mar; 118(11):. PubMed ID: 33836594
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Different antiganglioside antibody pattern between relapsing-remitting and progressive multiple sclerosis.
    Acarín N; Río J; Fernández AL; Tintoré M; Durán I; Galán I; Montalban X
    Acta Neurol Scand; 1996; 93(2-3):99-103. PubMed ID: 8741126
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased socioeconomic burden in patients with primary progressive multiple sclerosis: A Danish nationwide population-based study.
    Blinkenberg M; Kjellberg J; Ibsen R; Magyari M
    Mult Scler Relat Disord; 2020 Nov; 46():102567. PubMed ID: 33296969
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunological differences between classical phenothypes of multiple sclerosis.
    Iwanowski P; Losy J
    J Neurol Sci; 2015 Feb; 349(1-2):10-4. PubMed ID: 25586536
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of multiple sclerosis phenotypes on burden of disease in Finland.
    Purmonen T; Hakkarainen T; Tervomaa M; Ruutiainen J
    J Med Econ; 2020 Feb; 23(2):156-165. PubMed ID: 31617776
    [No Abstract]   [Full Text] [Related]  

  • 16. Adhesion molecules in multiple sclerosis: relation to subtypes of disease and methylprednisolone therapy.
    Elovaara I; Ukkonen M; Leppäkynnäs M; Lehtimäki T; Luomala M; Peltola J; Dastidar P
    Arch Neurol; 2000 Apr; 57(4):546-51. PubMed ID: 10768630
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-SPAG16 antibodies in primary progressive multiple sclerosis are associated with an elevated progression index.
    de Bock L; Fraussen J; Villar LM; Álvarez-Cermeño JC; Van Wijmeersch B; van Pesch V; Stinissen P; Somers V
    Eur J Neurol; 2016 Apr; 23(4):722-8. PubMed ID: 26706657
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic differences between primary progressive and relapsing-remitting multiple sclerosis: The impact of immune-related genes variability.
    Kiselev I; Bashinskaya V; Baulina N; Kozin M; Popova E; Boyko A; Favorova O; Kulakova O
    Mult Scler Relat Disord; 2019 Apr; 29():130-136. PubMed ID: 30711878
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of high mobility group box protein 1 (HMGB1) in peripheral blood from patients with multiple sclerosis.
    Malhotra S; Fissolo N; Tintoré M; Wing AC; Castilló J; Vidal-Jordana A; Montalban X; Comabella M
    J Neuroinflammation; 2015 Mar; 12():48. PubMed ID: 25879961
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-MOG autoantibodies in Italian multiple sclerosis patients: specificity, sensitivity and clinical association.
    Mantegazza R; Cristaldini P; Bernasconi P; Baggi F; Pedotti R; Piccini I; Mascoli N; La Mantia L; Antozzi C; Simoncini O; Cornelio F; Milanese C
    Int Immunol; 2004 Apr; 16(4):559-65. PubMed ID: 15039386
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.